Latest News

Judge Won’t Overturn Invalidated USMLE Scores


 

NBME Defends Departure From Traditional Procedures

In court documents, NBME disputed claims that it violated its own procedures by invalidating the exam scores. Giri’s report contends that examinees suspected of cheating are typically first advised of the matter, given an opportunity to share relevant information, and provided the right to appeal — during which time, their scores are treated as valid.

But the NBME said the USMLE program is authorized to take any actions it deems appropriate in response to concerns regarding score validity if the USMLE Committee for Individualized Review or the USMLE Composite Committee concludes that alternative or supplemental procedures are warranted in response to a given set of facts or circumstances.

“Following the month-long investigation and analysis…the USMLE program concluded that alternative procedures were warranted to address the score invalidity concerns identified in the interest of providing a process that is timely, efficient, effective, and fair, and given the large number of examinees involved in the investigation,” the board stated in its legal response.

In his order, Cooper wrote the current scenario, which implicates that more than 800 test-takers, is “clearly a situation calling for a procedure geared toward efficiency.” No evidence shows the board would not have taken similarly swift action if confronted with evidence of cheating on a comparable scale elsewhere, he wrote.

The judge also denied Giri’s motion to certify the lawsuit as a class action. The motion was denied without prejudice, meaning the plaintiff has the option to renew the motion should the case proceed.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Healthcare Workers Face Increased Risks During the Pandemic
MDedge ObGyn
Beware the Letter of Intent
MDedge ObGyn
Nepali IMG Sues NBME for Invalidating USMLE Scores in Cheating Scandal
MDedge ObGyn
Urologist Sues Health System Over Noncompete Clause
MDedge ObGyn
Unleashing Our Immune Response to Quash Cancer
MDedge ObGyn
Patients Want the Facts Delivered in a Personal Story
MDedge ObGyn
Is Mammography Ready for AI? Opinions Mixed on Usage, Cost Methods
MDedge ObGyn
Democratic Lawmakers Press Pfizer on Chemotherapy Drug Shortages
MDedge ObGyn
Communicating Bad News to Patients
MDedge ObGyn
Poor Quality of Cancer Content on Social Media
MDedge ObGyn